GNG11 and lung adenocarcinoma: Survival curve analysis revealed that lung adenocarcinoma patients with high expression of ZDHHC9 (Figure 8C), BTNL9 (Figure 8D–8F), GNG11 (Figure 8G, 8H) or CPED1 (Figure 8I–8K) are correlated with better survival outcomes.